Chimerism, resulting from the trafficking of donor's passenger cells from the transplanted organ into the recipient's body, was postulated to be responsible for the induction of donor-immune tolerance. These cells were able to inhibit donor-specific immune reactivity in patients who had reached transplant tolerance. However, in some series of longitudinal follow-up of recently transplanted patients, the amount of microchimerism could have great variation in individuals. Even in the same patient, the level of microchimerism could wax and wane in different post- transplantation periods. The relationship between microhimerism and rejection in these recently transplanted patients was also obscured. This study therfore followed up the existence ...
The relation between microchimerism and allograft tolerance is still a mystery. In this study we det...
After liver transplantation, migration of donor-derived hematopoietic cells to recipient can be dete...
Studies in experimental models (1953–1956) demonstrated that acquired donor-specific allotolerance i...
To determine the potential relevance of microchimerism to the long-term outcome of renal allograft, ...
To determine the potential relevance of microchimerism to the long-term outcome of renal allograft, ...
Microchimerism is a phenomenon which occurs in some recipients after kidney transplantation (KT) an...
Donor-type microchimerism is a phenomenon which occurs in some recipients after kidney transplantati...
Donor-type microchimerism, the presence of a minority population of donor-derived haematopoietic cel...
Chimerism was demonstrated with immunocytochemical and/or polymerase chain reaction techniques in ki...
Microchimerism (MC) is defined by the persistence of 50%. However, cytotoxic T-lymphocyte reactivity...
Chronic rejection and immunosuppression-related toxicity severely affect long-term outcomes of kidne...
Solid organ transplantation has achieved increased success during the past decade, largely related t...
After liver transplantation, migration of donor-derived hematopoietic cells to recipient can be dete...
Although the persistence of donor-type hematopoietic cells in low numbers (microchimerism) is well e...
The persistence of donor cells derived from the graft (chimerism) has been documented in various tis...
The relation between microchimerism and allograft tolerance is still a mystery. In this study we det...
After liver transplantation, migration of donor-derived hematopoietic cells to recipient can be dete...
Studies in experimental models (1953–1956) demonstrated that acquired donor-specific allotolerance i...
To determine the potential relevance of microchimerism to the long-term outcome of renal allograft, ...
To determine the potential relevance of microchimerism to the long-term outcome of renal allograft, ...
Microchimerism is a phenomenon which occurs in some recipients after kidney transplantation (KT) an...
Donor-type microchimerism is a phenomenon which occurs in some recipients after kidney transplantati...
Donor-type microchimerism, the presence of a minority population of donor-derived haematopoietic cel...
Chimerism was demonstrated with immunocytochemical and/or polymerase chain reaction techniques in ki...
Microchimerism (MC) is defined by the persistence of 50%. However, cytotoxic T-lymphocyte reactivity...
Chronic rejection and immunosuppression-related toxicity severely affect long-term outcomes of kidne...
Solid organ transplantation has achieved increased success during the past decade, largely related t...
After liver transplantation, migration of donor-derived hematopoietic cells to recipient can be dete...
Although the persistence of donor-type hematopoietic cells in low numbers (microchimerism) is well e...
The persistence of donor cells derived from the graft (chimerism) has been documented in various tis...
The relation between microchimerism and allograft tolerance is still a mystery. In this study we det...
After liver transplantation, migration of donor-derived hematopoietic cells to recipient can be dete...
Studies in experimental models (1953–1956) demonstrated that acquired donor-specific allotolerance i...